Morgan Stanley invested 0% in Inogen, Inc. (NASDAQ:INGN).
Jan 1, 2019 | whatsonthorold.com– Inogen has announced an agreement with Ashfield Healthcare to enhance its go-to-market capabilities.
Jan 1, 2021 | hmenews.comInogen, Inc. (NASDAQ: INGN ), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced the appointment of Kristin Caltrider as EVP & Chief Financial Officer, effective March 21, 2022.
Jan 1, 2022 | biospace.comInogen, Inc. (NASDAQ: INGN ), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced the appointment of Glenn Boehnlein, Kevin King, and Mary Katherine Ladone to Inogen’s Board of Directors, effective March 22, 2022.
Jan 1, 2022 | biospace.comInogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced the appointment of Agnes Lee to the position of Senior Vice President of Investor Relations and Strategic Planning, effective May 23, 2022.
Jan 1, 2022 | businesswire.comLee joins Inogen from Butterfly Network, where she served as vice president of Investor Relations.
Jan 1, 2022 | mpo-mag.comFor example, Inogen recently launched the Inogen One G5, which is a compact and lightweight medical oxygen concentrator.
Jan 1, 2022 | graphicalresearch.com